Excellent 4.6 out of 5
Solvents & Industrial Byproducts

3-Methylhippuric Acid (3MHA) Environmental Toxin Test

This urine test measures 3‑methylhippuric acid to detect your exposure to xylene solvents commonly found in paints, fuels, and adhesives, empowering you to cut hidden toxin exposure. Early detection can help you avoid headaches, dizziness, cognitive issues, respiratory irritation, and potential liver and kidney strain.

With Superpower, you have access to a comprehensive range of biomarker tests.

Test for 3-Methylhippuric Acid (3MHA)
Cancel anytime
HSA/FSA eligible
Results in a week
Physician reviewed

Every result is checked

·
CLIA-certified labs

Federal standard for testing

·
HIPAA compliant

Your data is 100% secure

Key Insights

  • See your current exposure to m‑xylene — via its urinary metabolite 3‑methylhippuric acid — and how it compares with typical levels.
  • Identify meaningful exposure patterns and potential sources (fresh paint or solvents, gasoline fumes, nail products, industrial settings, home renovation, poor ventilation).
  • Clarify whether xylene exposure could be contributing to symptom clusters like headaches, lightheadedness, throat or eye irritation, or liver workload.
  • Support reproductive planning or pregnancy safety by checking for elevations during sensitive life stages when solvent exposure is more concerning.
  • Track trends over time after changing products, improving ventilation, or adjusting occupational protections.
  • Inform conversations with your clinician about whether to evaluate related solvent exposures, discuss workplace controls, or consider targeted reduction strategies aligned with occupational guidelines.

What is 3‑Methylhippuric Acid (3MHA)?

3‑Methylhippuric acid (3MHA) is a breakdown product your body makes after exposure to m‑xylene, one of the xylene solvents found in paints, paint thinners, adhesives, gasoline, printing inks, and certain industrial processes. Most exposure happens by inhaling vapors during tasks like painting a room, pumping gas at a busy station, or working in auto body and nail salons; skin contact can contribute, too. Labs typically measure 3MHA in urine, often adjusted for creatinine to account for hydration, and the result reflects recent exposure over roughly the past day.

Why it matters: xylene is a volatile aromatic hydrocarbon that can irritate the eyes and airways and transiently affect the nervous system, which is why people sometimes notice headaches, dizziness, or that “solvent smell.” After inhalation, the liver uses enzymes such as CYP2E1 to convert m‑xylene to methylbenzoic acids that are then conjugated with glycine to form methylhippuric acids, which the kidneys excrete in urine. Xylenes do not typically bioaccumulate like heavy metals, so levels rise and fall with exposure patterns. Still, repeated daily exposures can keep the body in a steady state of handling more solvent than usual, and that’s when testing becomes informative.

Why Is It Important to Test For 3MHA?

Measuring 3MHA links the chemistry to real life. It helps distinguish a brief, incidental encounter — say, rolling on a fresh coat of paint in a well‑ventilated room — from sustained exposure that might occur in certain workplaces or during a home renovation with poor airflow. That distinction can clarify whether recent xylene contact aligns with symptoms like headache, fatigue, throat or eye irritation, or whether it tracks with specific settings such as end‑of‑shift spikes after solvent use. Testing is especially informative for people who are pregnant or planning pregnancy, and for workers in high‑exposure environments like painting, printing, autobody repair, and nail services, where occupational health benchmarks exist for methylhippuric acids.

Big picture, a 3MHA result sits alongside other environmental markers, general health labs, and your day‑to‑day context. Patterns across multiple solvent metabolites, plus symptom timing and exposure notes, offer a more reliable picture than any single data point. Trends over weeks to months — especially when you change products, improve ventilation, or rotate tasks — are what separate one‑off spikes from persistent exposure that deserves focused attention with a clinician or occupational health specialist.

What Insights Will I Get From a 3MHA Test?

Labs report 3MHA as a number, often with a reference interval derived from population data or occupational guidelines. Because this is an exposure marker, lower values are generally preferable when feasible. Interpretation improves when you know what happened in the 24 to 48 hours before the test — for example, whether you painted, used solvents, or worked a solvent‑heavy shift — and when results are creatinine‑normalized or collected at similar times to reduce the impact of hydration. End‑of‑shift testing can capture peak exposure, while off‑shift testing shows your baseline.

When values sit toward the lower end of typical ranges, that usually signals limited recent contact with m‑xylene and a lower likelihood of short‑term nervous system or airway irritation. In low‑exposure households and office environments, many people fall near this zone. During pregnancy and early childhood, keeping solvent exposures low is preferred because developing systems are more sensitive, so relatively lower results are reassuring in those contexts.

Higher values tend to indicate recent or ongoing exposure. That might reflect a weekend remodel with oil‑based paint, daily solvent use at work, or frequent time around gasoline or degreasers. Biologically, sustained elevations mean the liver and kidneys are processing more xylene — hepatic enzymes ramp metabolism, and the kidneys excrete more methylhippuric acids — and symptoms, if present, often show up as headaches, lightheadedness, throat or eye irritation, or a sense of mental fog after solvent tasks. Because hydration, timing, and task variability influence any single reading, confirmation with repeat testing and exposure notes is the most reliable way to sort a transient spike from a pattern.

Your 3MHA result is most actionable when viewed next to related solvent biomarkers, routine health indicators, and lived context. Over time, that combination helps map whether exposures are sporadic or sustained, links values to specific tasks or products, and supports smarter changes with your clinician’s guidance without guessing in the dark.

How This Test Fits Into Real Life

Think of 3MHA as your xylene “receipt.” Paint a bedroom on Saturday, and a Sunday urine test will likely capture that contact; wait a few days with clean air and it often drifts back down, since xylenes clear relatively quickly. In contrast, an auto body technician or a nail professional may see a recurring pattern — higher after workdays, lower after weekends — that mirrors the shop’s ventilation and product mix. Those patterns are navigational, not judgmental, and they pair naturally with practical control steps discussed with an employer or clinician.

What Affects Results

Timing matters because 3MHA reflects recent exposure. End‑of‑shift or first‑morning samples are common approaches for consistency. Hydration can dilute or concentrate urine; creatinine‑normalized reporting helps control for that. The test is specific to m‑xylene exposure, so it does not capture o‑ and p‑xylene equally — some labs measure the sum of methylhippuric acids to reflect total xylenes. Co‑exposures to other solvents may drive overlapping symptoms without moving 3MHA, which is why broader panels sometimes include other markers. Individual differences in liver enzyme activity can influence metabolite levels for the same exposure, and laboratory methods vary in sensitivity and reporting ranges, so comparing results across different labs should be done cautiously.

Safety and Sensitivities

Solvent sensitivity is real. People with asthma or chronic airway irritation may notice symptoms at lower exposures than others. Pregnancy is a special case because solvents cross the placenta; professional bodies in occupational health highlight exposure minimization during this life stage. Children can inhale proportionally more air per body weight during the same task, making ventilation and time around solvent sources more relevant. None of this means everyday life must be sterile — it simply underscores that your 3MHA value is a helpful yardstick for aligning daily habits with comfort and safety.

Quality and Credibility Notes

3MHA is a well‑established biomarker used in occupational hygiene, with biological exposure indices that anchor interpretation in real data, though ranges and action thresholds differ by agency and setting. Like any single biomarker, it is not a diagnosis; it is a measurement that earns its keep when paired with exposure history and repeat testing. Laboratories use validated methods, but pre‑test conditions and timing drive much of the story, so keep track of tasks, products, and environments around each sample to get the most from your results.

Superpower also tests for

See more diseases

Frequently Asked Questions About

What is a 3-Methylhippuric Acid (3MHA) test?

This test measures urinary 3‑methylhippuric acid, a metabolite and exposure marker of m‑xylene (a xylene isomer).

Its presence and concentration reflect recent inhalation or dermal exposure to m‑xylene and are used in occupational and environmental monitoring, since xylene is rapidly metabolized and excreted as methylhippuric acids in urine within about 24 hours.

Should I test for 3-Methylhippuric Acid (3MHA)?

Testing for 3‑Methylhippuric Acid (3MHA) can be useful if you suspect recent xylene exposure because 3MHA is a urinary metabolite of m‑xylene and reflects short‑term (hours–days) inhalation or dermal contact; knowing levels helps confirm exposure, correlate with symptoms, and track whether source‑control or protective measures are reducing body burden.

Common sources include industrial solvents, paints and coatings, gasoline and vehicle exhaust, adhesives, printing and some manufacturing processes (including plastics-related industries); exposure can cause acute central nervous system effects (headache, dizziness, drowsiness) and with repeated high exposures has been linked to longer‑term neurobehavioral, liver or kidney effects in occupational studies. Testing is practical because a measured urinary 3MHA level pinpoints recent xylene uptake and lets you prioritize ventilation, personal protective equipment, substitution of products, or other exposure‑reduction steps.

Who benefits most: workers in painting, petrochemical, printing, automotive or solvent‑using industries; residents near heavy traffic or industrial sites; people with unexplained neurocognitive, respiratory or chemical‑sensitivity symptoms; those with fertility or thyroid concerns who want to rule out solvent exposure as a factor; and individuals monitoring exposure reduction while optimizing detox capacity or longevity strategies.

How often should I test for 3-Methylhippuric Acid (3MHA)?

Obtain a baseline 3‑Methylhippuric Acid (3MHA) test once to assess exposure, then have periodic follow‑up testing if initial levels are elevated—typically every few months or as recommended by your clinician—to monitor trends; also retest after significant lifestyle or environmental changes (for example, after changing household products or following detoxification efforts) or after changes in workplace exposure to confirm improvement or detect re‑exposure.

What can affect 3-Methylhippuric Acid (3MHA) test results?

3‑Methylhippuric Acid (3MHA) test results can be affected by timing of sample collection (levels change after exposure), recent exposure from food, air, water or consumer products, individual metabolism (including genetic and liver function differences), hydration status (which alters urine concentration), and the type of sample collected (urine vs. blood); certain medications or dietary supplements may also influence readings.

Are there any preparations needed before testing 3-Methylhippuric Acid (3MHA) levels?

No fasting is needed for 3‑methylhippuric acid (3MHA) testing. Whether a first‑morning urine is preferred depends on the purpose: a first‑morning sample can give a consistent baseline, but occupational or recent‑exposure testing is often done on a timed or end‑of‑shift sample — follow the testing laboratory or clinician’s instructions for timing.

It is advisable to avoid obvious non‑work solvent exposures before the test when practical (for example: paints, paint thinners, gasoline, glues/adhesives, certain hobby solvents, heavy use of solvent‑containing cleaning products, and smoking) and to note any recent contact with plastics, personal care products, pesticides, or other chemical products that might contain aromatic solvents. Also note any unusual environmental contact or product use on the sample form; labs commonly adjust for urine concentration (creatinine or specific gravity), so avoid extreme dehydration or excessive fluid loading just before collection unless instructed otherwise.

How accurate is 3-Methylhippuric Acid (3MHA) testing?

3MHA reflects recent or short‑term exposure rather than long‑term body burden because it is a rapidly excreted metabolite; therefore a single spot urine result shows recent uptake but not cumulative exposure over weeks or months. Accuracy is most influenced by sample timing relative to exposure, the laboratory method used (mass spectrometry–based methods give the most accurate and specific results), and consistent collection practices (timed or standardized spot samples, and correction for urine concentration such as creatinine or specific gravity).

What happens if my 3-Methylhippuric Acid (3MHA) levels are outside the optimal or reference range?

Higher-than‑reference 3‑Methylhippuric Acid (3MHA) levels most commonly indicate increased recent exposure to the parent chemical (for example from environmental or occupational sources, consumer products, or indoor air) or reduced clearance by the body (slower metabolism or impaired kidney/liver function), while lower‑than‑expected levels may reflect minimal exposure or rapid elimination. Elevated results do not prove harm by themselves but signal that exposure has occurred or that the body is not removing the compound as quickly as typical.

Results must be interpreted in context — alongside other toxin markers, lifestyle factors (smoking, hobbies, work), and clinical/laboratory indicators of liver or kidney health — rather than alone. Typical next steps include reducing or removing potential exposure sources, repeating testing to confirm trends, and discussing findings with a clinician or occupational health professional for targeted evaluation and any needed medical follow‑up.

How do I interpret my 3-Methylhippuric Acid (3MHA) test results?

3‑Methylhippuric acid (3MHA) is a urinary metabolite used mainly to indicate recent exposure to certain xylene isomers; higher-than-reference results suggest recent or ongoing exposure, while low or undetectable values generally indicate little or no recent exposure. Interpretation depends on the laboratory’s reference range and whether the result is creatinine‑corrected — labs often report both absolute and creatinine‑adjusted values because urine concentration and timing of collection (3MHA reflects recent exposure, often within hours to a few days) affect levels.

Always interpret a single 3MHA result in context: review trends over time (serial measurements are more informative than one-off values) and compare with related toxin markers and body‑system indicators such as liver and kidney function tests and oxidative‑stress or inflammation biomarkers. Consider known exposure history (workplace, hobbies, spills, solvents) when deciding if an elevated value is clinically or occupationally significant, and discuss abnormal or changing results with a clinician or occupational health professional for advice on exposure reduction and further testing.

How it works

1

Test your whole body

Get a comprehensive blood draw at one of our 3,000+ partner labs or from the comfort of your own home.

2

An Actionable Plan

Easy to understand results & a clear action plan with tailored recommendations on diet, lifestyle changes, supplements and pharmaceuticals.

3

A Connected Ecosystem

You can book additional diagnostics, buy curated supplements for 20% off & pharmaceuticals within your Superpower dashboard.

Superpower tests more than 
100+ biomarkers & common symptoms

Developed by world-class medical professionals

Supported by the world’s top longevity clinicians and MDs.

Dr Anant Vinjamoori

Superpower Chief Longevity Officer, Harvard MD & MBA

A smiling woman wearing a white coat and stethoscope poses for a portrait.

Dr Leigh Erin Connealy

Clinician & Founder of The Centre for New Medicine

Man in a black medical scrub top smiling at the camera.

Dr Abe Malkin

Founder & Medical Director of Concierge MD

Dr Robert Lufkin

UCLA Medical Professor, NYT Bestselling Author

membership

$17

/month
Billed annually at $199
A smartphone displays health app results, showing biomarker summary, superpower score, and biological age details.
A website displays a list of most ordered products including a ring, vitamin spray, and oil.
A smartphone displays health app results, showing biomarker summary, superpower score, and biological age details.A tablet screen shows a shopping website with three most ordered products: a ring, supplement, and skincare oil.
What could cost you $15,000 is $199

Superpower
Membership

Your membership includes one comprehensive blood draw each year, covering 100+ biomarkers in a single collection
One appointment, one draw for your annual panel.
100+ labs tested per year
A personalized plan that evolves with you
Get your biological age and track your health over a lifetime
$
17
/month
billed annually
Flexible payment options
Four credit card logos: HSA/FSA Eligible, American Express, Visa, and Mastercard.
Start your Women’s Health Check
Cancel anytime
HSA/FSA eligible
Results in a week
Pricing may vary for members in New York and New Jersey **

Finally, healthcare that looks at the whole you